1. Davidkin I; Valle M; Julkunen I. Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up.Vaccine 1995;13(16):1617-22.
2. Chomel JJ; Robin Y; Durdilly R; Thouvenot D; Langlois M; Aymard M.Rapid direct diagnosis of mumps meningitis by ELISA capture technique. J Virol Methods 1997;68(1):97-104.
3. Nigro G; Nanni F; Midulla M. Determination of vaccine-induced and naturally acquired class-specific mumps antibodies by two indirect enzyme-linked immunosorbent assays. J Virol Methods 1986;13(2):91-106.
4. Harmsen T; Jongerius MC; van der Zwan CW; Plantinga AD; Kraaijeveld CA; Berbers GA. Comparison of a neutralization enzyme immunoassay and an enzyme-linked immunosorbent assay for evaluation of immune status of children vaccinated for mumps. J Clin Microbiol 1992;30(8):2139-44.
5. Novotn´y J. Properties and use of mumps viral antigen for detection of specific IgG and IgM antibodies in enzyme-linked immunosorbent assay. Acta Virol 1990;34(6):574-7.
6. Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years. Pediatr Infect Dis J 1996; 15(8):687-92.